Thanks, Rob, and good morning to everyone. Despite macroeconomic headwinds in Q3, we grew our portfolio by $57 million in the quarter and finished the quarter with a portfolio of $635 million. We funded 7 transactions totaling $89 million, including $84 million in debt investments, 5 new portfolio companies consisting of 3 new tech investments, 1 new life science investment and 1 new health care tech investment, providing further diversification to our portfolio. Our onboarding yield of 12.9% during the quarter was well above last quarter's yield and reflects the value of our portfolio's floating rate interest rates in a rising rate environment as well as our continued discipline in structuring and pricing transactions to produce strong net investment income. We experienced 2 loan prepayments during the quarter totaling $22 million. Prepayments were the result of 2 of our portfolio companies completing SPAC transactions. Prepayment fees and accelerated end-of-term payment income from those transactions further contributed to a strong debt portfolio yield of 15.9% and reflects how our predictive pricing strategy generates one of the highest portfolio yields in the BDC industry. As we have indicated over the past few quarters, given the current macro environment, we anticipate prepayments in the fourth quarter may be lighter than in prior years. As of September 30, we held warrant and equity positions in 94 portfolio companies, with a fair value of $24 million. As we've consistently noted, structuring investments with warrants and equity rights is a key aspect of our venture debt strategy and an additional value generator. In the third quarter, we closed $194 million in new loan commitments and approvals and ended the quarter with a record committed and approved backlog of $252 million compared to $221 million at the end of the second quarter. Most of our funding commitments are subject to our portfolio companies meeting certain key milestones. Meeting these milestones not only unlocks new debt investments for us and our portfolio companies but positively impacts the credit profile of our existing debt investments, thus de-risking our investment portfolio. With the uncertainty of the macroeconomic outlook over the next few quarters, there is greater-than-usual uncertainty that milestones will be met and future fundings made from our committed backlog. That said, as we enter the fourth quarter with a record committed backlog, Horizon is in a strong position to responsibly continue to grow its portfolio as we closely monitor the performance of our portfolio companies and macroeconomic conditions. Our portfolio's credit quality remains solid, as shown by the fair value of 97% of our debt portfolio consisting of 3 and 4-rated loans as of September 30, an improvement from the prior quarter end. Of note, we had no 1-rated credits at the end of the quarter. One of our 1-rated credits at the end of Q2, Kite Hill, was able to raise fresh equity to recapitalize the company and return to a 3-rated credit. And our other 1-rated credit at the end of Q2, MacuLogix, completed a sale of assets through an ABC liquidation sale. We had 3 portfolio companies out of a total of 57 with a 2 rating at the end of Q3. Obviously, we continue to closely follow our portfolio of companies and are in continual communication with them. Turning now to the venture capital environment. As expected, VC investment activity continues to lighten as investors become more hesitant in the current environment. According to PitchBook, approximately $43 billion was invested in VC-backed companies in the third quarter of 2022, still a healthy flow but the lowest quarterly total since the second quarter of 2020. While the VC fundraising has already surpassed last year's record total, the $29 billion raised in the third quarter represented a quarter-over-quarter decline. Funds with established managers drove the bulk of the VC fundraising. Meanwhile, VC-backed exit activity remains muted given the current environment and the near shutting of the IPO window. Total exit value for the quarter was $14 billion, just above last quarter's total. And it's likely that the exit value for the year will fall below $100 billion for the first time since 2016. While the economic environment and investor sentiment remains challenging, VC firms continue to maintain record levels of dry investment powder, nearly $300 billion, which may provide liquidity for new investment opportunities and to support existing portfolio companies. Demand for venture debt has tightened recently, but we continue to see opportunities to invest in growth-stage companies. We are also watching closely to see if the tech-oriented banks begin to pull away from the venture debt market. Should this occur, it may create additional opportunity for our adviser to source and originate high-quality venture debt loans for us. Given our adviser's strong and active lending platform and the solid investment capacity of Horizon, we believe Horizon is well situated to compete for and win opportunistic investments in the current environment. Subsequent to the end of the third quarter, we funded 2 new transactions totaling $10 million. Our committed, approved and awarded backlog as of today stands at $282 million. Our adviser's pipeline of new opportunities today remains over $1 billion in a historic high. Looking ahead, we expect a challenging environment to carry into 2023, but believe there are still attractive quality companies that are looking for venture debt solutions. This provides an opportunity to continue to selectively grow our portfolio, our committed backlog and our adviser's pipeline. We will also continue to squarely focus on credit quality to ensure optimal outcomes. We believe we remain well positioned to continue to deliver additional long-term shareholder value. With that, I will now turn the call over to Dan.